$4.33 Billion is the total value of Rock Springs Capital Management LP's 136 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 16.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AGL | Buy | AGILON HEALTH INC | $202,365,000 | +9.1% | 7,495,000 | +5.9% | 4.68% | +19.9% |
| HUM | Buy | HUMANA INC | $161,887,000 | +21.6% | 349,000 | +2.0% | 3.74% | +33.7% |
| ALGN | ALIGN TECHNOLOGY INC | $131,436,000 | -1.2% | 200,000 | 0.0% | 3.04% | +8.5% | |
| ISRG | Buy | INTUITIVE SURGICAL INC | $129,348,000 | +8.4% | 360,000 | +200.0% | 2.99% | +19.1% |
| PODD | Buy | INSULET CORP | $123,390,000 | -0.8% | 463,750 | +6.0% | 2.85% | +9.0% |
| UNH | UNITEDHEALTH GROUP INC | $120,514,000 | +28.5% | 240,000 | 0.0% | 2.78% | +41.2% | |
| IDXX | IDEXX LABS INC | $118,523,000 | +5.9% | 180,000 | 0.0% | 2.74% | +16.3% | |
| HCA | HCA HEALTHCARE INC | $115,614,000 | +5.9% | 450,000 | 0.0% | 2.67% | +16.3% | |
| ARGX | ARGENX SEsponsored adr | $110,310,000 | +16.0% | 315,000 | 0.0% | 2.55% | +27.4% | |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $94,113,000 | -6.7% | 1,105,000 | +5.1% | 2.17% | +2.5% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $92,088,000 | +5.4% | 859,755 | +1.2% | 2.13% | +15.8% |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $86,995,000 | -26.3% | 2,646,625 | +3.5% | 2.01% | -19.0% |
| IMCR | Buy | IMMUNOCORE HLDGS PLCads | $84,626,000 | -6.6% | 2,471,555 | +1.1% | 1.96% | +2.6% |
| HZNP | Buy | HORIZON THERAPEUTICS PUB L | $80,389,000 | +4.5% | 746,000 | +6.3% | 1.86% | +14.8% |
| EW | EDWARDS LIFESCIENCES CORP | $75,398,000 | +14.4% | 582,000 | 0.0% | 1.74% | +25.8% | |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $74,329,000 | +2.9% | 883,921 | +10.3% | 1.72% | +13.0% |
| ZLAB | Buy | ZAI LAB LTDadr | $74,207,000 | -34.7% | 1,180,700 | +9.6% | 1.71% | -28.2% |
| BAX | Buy | BAXTER INTL INC | $62,990,000 | +74.0% | 733,803 | +63.1% | 1.46% | +91.2% |
| NVAX | Sell | NOVAVAX INC | $60,805,000 | -35.5% | 425,000 | -6.6% | 1.40% | -29.1% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $60,204,000 | -3.7% | 410,415 | +16.1% | 1.39% | +5.8% |
| PCRX | PACIRA BIOSCIENCES INC | $60,170,000 | +7.4% | 1,000,000 | 0.0% | 1.39% | +18.1% | |
| NVRO | Buy | NEVRO CORP | $57,884,000 | -21.8% | 714,000 | +12.3% | 1.34% | -14.1% |
| EVH | Buy | EVOLENT HEALTH INCcl a | $56,391,000 | -3.0% | 2,038,000 | +8.7% | 1.30% | +6.6% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $56,385,000 | -4.0% | 332,500 | +6.9% | 1.30% | +5.5% |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $56,144,000 | -18.0% | 3,861,347 | +1.5% | 1.30% | -9.9% |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $55,916,000 | +16.6% | 426,843 | +8.9% | 1.29% | +28.2% |
| FRPT | Buy | FRESHPET INC | $55,257,000 | -26.5% | 580,000 | +10.1% | 1.28% | -19.2% |
| ASND | ASCENDIS PHARMA A/Ssponsored adr | $53,812,000 | -15.6% | 400,000 | 0.0% | 1.24% | -7.3% | |
| CERE | Buy | CEREVEL THERAPEUTICS HLDNG I | $53,442,000 | +13.2% | 1,648,435 | +3.0% | 1.24% | +24.4% |
| IRTC | Sell | IRHYTHM TECHNOLOGIES INC | $50,960,000 | +94.2% | 433,000 | -3.3% | 1.18% | +113.2% |
| KYMR | Buy | KYMERA THERAPEUTICS INC | $47,114,000 | +9.4% | 742,065 | +1.2% | 1.09% | +20.3% |
| ACHC | Buy | ACADIA HEALTHCARE COMPANY IN | $45,434,000 | +0.3% | 748,500 | +5.4% | 1.05% | +10.3% |
| EXAS | EXACT SCIENCES CORP | $44,363,000 | -18.5% | 570,000 | 0.0% | 1.02% | -10.4% | |
| NVTA | Buy | INVITAE CORP | $42,760,000 | -42.3% | 2,800,243 | +7.5% | 0.99% | -36.6% |
| PEN | Buy | PENUMBRA INC | $42,667,000 | +8.5% | 148,500 | +0.7% | 0.99% | +19.2% |
| SWAV | Buy | SHOCKWAVE MED INC | $39,678,000 | -12.4% | 222,500 | +1.1% | 0.92% | -3.7% |
| SGEN | Buy | SEAGEN INC | $39,578,000 | -6.8% | 256,000 | +2.4% | 0.91% | +2.4% |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $38,181,000 | +18.0% | 424,000 | +21.1% | 0.88% | +29.5% |
| ARVN | Sell | ARVINAS INC | $37,554,000 | -20.9% | 457,200 | -20.8% | 0.87% | -13.0% |
| CYTOKINETICS INCnote 4.000%11/1 | $35,665,000 | +26.0% | 8,000,000 | 0.0% | 0.82% | +38.5% | ||
| Buy | WARBY PARKER INC | $33,709,000 | -2.2% | 724,000 | +11.4% | 0.78% | +7.4% | |
| HCAT | Buy | HEALTH CATALYST INC | $33,685,000 | -20.8% | 850,200 | +0.0% | 0.78% | -13.0% |
| VERV | Sell | VERVE THERAPEUTICS INC | $33,291,000 | -26.4% | 902,926 | -6.2% | 0.77% | -19.1% |
| CVET | Buy | COVETRUS INC | $33,184,000 | +12.7% | 1,661,700 | +2.4% | 0.77% | +23.9% |
| EHC | Buy | ENCOMPASS HEALTH CORP | $32,793,000 | -12.6% | 502,500 | +0.5% | 0.76% | -3.9% |
| PHR | Sell | PHREESIA INC | $32,078,000 | -46.4% | 770,000 | -20.6% | 0.74% | -41.1% |
| PRTA | Sell | PROTHENA CORP PLC | $31,998,000 | -36.8% | 647,730 | -8.8% | 0.74% | -30.5% |
| ACCD | Buy | ACCOLADE INC | $31,553,000 | -18.9% | 1,197,000 | +29.7% | 0.73% | -10.9% |
| DXCM | Buy | DEXCOM INC | $30,472,000 | +19.8% | 56,750 | +22.0% | 0.70% | +31.6% |
| TVTX | Sell | TRAVERE THERAPEUTICS INC | $29,539,000 | -18.6% | 951,650 | -36.4% | 0.68% | -10.6% |
| ABCM | Buy | ABCAM PLCads | $29,496,000 | +26.8% | 1,252,500 | +9.1% | 0.68% | +39.3% |
| CNMD | Buy | CONMED CORP | $28,706,000 | +35.0% | 202,500 | +24.6% | 0.66% | +48.3% |
| GRPH | Buy | GRAPHITE BIO INC | $25,841,000 | -24.1% | 2,078,910 | +0.1% | 0.60% | -16.6% |
| SRRA | Sell | SIERRA ONCOLOGY INC | $25,757,000 | -10.6% | 1,184,793 | -9.8% | 0.60% | -1.8% |
| XENT | Sell | INTERSECT ENT INC | $25,671,000 | -22.6% | 940,000 | -23.0% | 0.59% | -15.0% |
| MIRM | Buy | MIRUM PHARMACEUTICALS INC | $24,544,000 | -19.2% | 1,538,814 | +0.9% | 0.57% | -11.3% |
| RXDX | Buy | PROMETHEUS BIOSCIENCES INC | $24,452,000 | +69.0% | 618,407 | +1.4% | 0.56% | +85.9% |
| XENE | Buy | XENON PHARMACEUTICALS INC | $24,098,000 | +170.5% | 771,367 | +32.3% | 0.56% | +197.9% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $23,324,000 | +19.0% | 264,000 | +4.1% | 0.54% | +30.8% |
| MDGL | Buy | MADRIGAL PHARMACEUTICALS INC | $22,829,000 | +9.0% | 269,400 | +2.6% | 0.53% | +19.8% |
| LUNG | PULMONX CORP | $22,449,000 | -10.9% | 700,000 | 0.0% | 0.52% | -2.1% | |
| DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $22,187,000 | -19.2% | 1,576,894 | +10.3% | 0.51% | -11.2% |
| WST | Buy | WEST PHARMACEUTICAL SVSC INC | $21,340,000 | +67.6% | 45,500 | +51.7% | 0.49% | +84.0% |
| MRSN | Buy | MERSANA THERAPEUTICS INC | $20,208,000 | -29.1% | 3,248,950 | +7.6% | 0.47% | -22.0% |
| GH | GUARDANT HEALTH INC | $20,004,000 | -20.0% | 200,000 | 0.0% | 0.46% | -12.2% | |
| New | XILIO THERAPEUTICS INC | $19,058,000 | – | 1,191,094 | +100.0% | 0.44% | – | |
| LFST | Buy | LIFESTANCE HEALTH GROUP INC | $19,040,000 | -22.2% | 2,000,000 | +18.5% | 0.44% | -14.4% |
| LEGN | Buy | LEGEND BIOTECH CORPsponsored ads | $18,811,000 | +18.0% | 403,584 | +28.0% | 0.44% | +29.9% |
| ANAB | Buy | ANAPTYSBIO INC | $18,720,000 | +28.8% | 538,700 | +0.5% | 0.43% | +41.5% |
| RLAY | Buy | RELAY THERAPEUTICS INC | $18,357,000 | +24.0% | 597,767 | +27.3% | 0.42% | +36.3% |
| IMMUNEERING CORP | $17,622,000 | -39.1% | 1,089,816 | 0.0% | 0.41% | -33.1% | ||
| New | AURA BIOSCIENCES INC | $17,118,000 | – | 1,008,114 | +100.0% | 0.40% | – | |
| CMPX | New | COMPASS THERAPEUTICS INC | $16,890,000 | – | 5,328,088 | +100.0% | 0.39% | – |
| Buy | ICOSAVAX INC | $16,828,000 | -22.5% | 735,504 | +0.2% | 0.39% | -14.9% | |
| SPRO | Buy | SPERO THERAPEUTICS INC | $15,134,000 | -12.7% | 945,313 | +0.4% | 0.35% | -3.8% |
| Sell | GOSSAMER BIO INCnote 5.000% 6/0 | $15,066,000 | -7.3% | 15,373,000 | -1.3% | 0.35% | +1.8% | |
| AMRN | Buy | AMARIN CORP PLCspons adr new | $14,894,000 | -32.4% | 4,419,700 | +2.3% | 0.34% | -25.7% |
| AMYT | Buy | AMRYT PHARMA PLCsponsored ads | $14,103,000 | -9.6% | 1,305,825 | +0.8% | 0.33% | -0.6% |
| MGNX | Buy | MACROGENICS INC | $13,758,000 | +2.4% | 857,205 | +33.6% | 0.32% | +12.4% |
| COLL | Sell | COLLEGIUM PHARMACEUTICAL INC | $13,543,000 | -23.8% | 725,000 | -19.4% | 0.31% | -16.3% |
| NVCR | NOVOCURE LTD | $13,139,000 | -35.4% | 175,000 | 0.0% | 0.30% | -28.8% | |
| Sell | AADI BIOSCIENCE INC | $13,013,000 | -42.1% | 538,835 | -29.5% | 0.30% | -36.2% | |
| RIGL | Buy | RIGEL PHARMACEUTICALS INC | $12,880,000 | -26.0% | 4,860,200 | +1.4% | 0.30% | -18.6% |
| AKRO | Buy | AKERO THERAPEUTICS INC | $12,417,000 | -2.3% | 587,101 | +3.2% | 0.29% | +7.5% |
| KDNY | Buy | CHINOOK THERAPEUTICS INC | $11,749,000 | +33.8% | 720,349 | +4.7% | 0.27% | +46.5% |
| FOLD | AMICUS THERAPEUTICS INC | $11,694,000 | +20.9% | 1,012,506 | 0.0% | 0.27% | +33.0% | |
| LPTX | Buy | LEAP THERAPEUTICS INC | $11,407,000 | -18.9% | 3,520,570 | +0.4% | 0.26% | -10.8% |
| ABOS | Sell | ACUMEN PHARMACEUTICALS INC | $10,626,000 | -54.7% | 1,571,918 | -0.5% | 0.25% | -50.1% |
| AUPH | Sell | AURINIA PHARMACEUTICALS INC | $10,456,000 | -23.0% | 457,173 | -25.5% | 0.24% | -15.1% |
| CGEM | Sell | CULLINAN ONCOLOGY INC | $9,969,000 | -58.9% | 646,078 | -40.0% | 0.23% | -55.0% |
| OHPAU | ORION ACQUISITION CORPunit 02/19/2026 | $9,850,000 | -0.5% | 1,000,000 | 0.0% | 0.23% | +9.6% | |
| RPHM | RENEO PHARMACEUTICALS INC | $9,774,000 | +14.8% | 1,143,185 | 0.0% | 0.23% | +26.3% | |
| EPZM | Buy | EPIZYME INC | $9,519,000 | -48.3% | 3,807,662 | +5.9% | 0.22% | -43.2% |
| OLK | Buy | OLINK HLDG ABsponsored ads | $9,373,000 | -23.5% | 515,000 | +2.0% | 0.22% | -15.6% |
| NRIX | Buy | NURIX THERAPEUTICS INC | $9,294,000 | -2.6% | 321,050 | +0.8% | 0.22% | +7.0% |
| MREO | Buy | MEREO BIOPHARMA GROUP PLCads | $8,937,000 | -23.6% | 5,585,621 | +15.6% | 0.21% | -16.3% |
| BMEA | BIOMEA FUSION INC | $8,684,000 | -37.8% | 1,165,582 | 0.0% | 0.20% | -31.4% | |
| ADAP | Buy | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $8,308,000 | -26.6% | 2,215,588 | +1.2% | 0.19% | -19.3% |
| VINC | Buy | VINCERX PHARMA INC | $8,246,000 | -36.3% | 809,195 | +1.1% | 0.19% | -29.8% |
| FULC | Buy | FULCRUM THERAPEUTICS INC | $8,084,000 | -37.1% | 456,990 | +0.4% | 0.19% | -30.7% |
| NKTX | Buy | NKARTA INC | $7,786,000 | -44.4% | 507,248 | +0.8% | 0.18% | -38.8% |
| PRTK | Buy | PARATEK PHARMACEUTICALS INC | $7,620,000 | -5.8% | 1,697,105 | +1.9% | 0.18% | +3.5% |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $7,492,000 | -40.3% | 1,577,296 | 0.0% | 0.17% | -34.5% | |
| EPIX | Buy | ESSA PHARMA INC | $7,257,000 | +78.6% | 511,044 | +0.6% | 0.17% | +97.6% |
| SPRB | Buy | SPRUCE BIOSCIENCES INC | $7,237,000 | -25.6% | 1,622,689 | +0.3% | 0.17% | -18.1% |
| ATHA | ATHIRA PHARMA INC | $7,196,000 | +38.9% | 552,252 | 0.0% | 0.17% | +52.3% | |
| DSGN | Buy | DESIGN THERAPEUTICS INC | $7,178,000 | +46.3% | 335,247 | +0.4% | 0.17% | +61.2% |
| PHAS | Buy | PHASEBIO PHARMACEUTICALS INC | $6,737,000 | +17.5% | 2,581,299 | +40.0% | 0.16% | +28.9% |
| DAWN | Buy | DAY ONE BIOPHARMACEUTICALS I | $6,436,000 | -28.0% | 381,939 | +1.5% | 0.15% | -20.7% |
| FATE | FATE THERAPEUTICS INC | $6,436,000 | -1.3% | 110,000 | 0.0% | 0.15% | +8.8% | |
| RYTM | Buy | RHYTHM PHARMACEUTICALS INC | $6,259,000 | -21.7% | 627,180 | +2.5% | 0.14% | -13.7% |
| APLT | APPLIED THERAPEUTICS INC | $6,280,000 | -46.1% | 701,680 | 0.0% | 0.14% | -40.8% | |
| KNTE | Buy | KINNATE BIOPHARMA INC | $6,022,000 | -21.4% | 339,846 | +2.1% | 0.14% | -13.7% |
| INZY | Buy | INOZYME PHARMA INC | $5,923,000 | -39.9% | 868,466 | +2.2% | 0.14% | -33.8% |
| New | THESEUS PHARMACEUTICALS INC | $5,545,000 | – | 437,329 | +100.0% | 0.13% | – | |
| CGEN | Buy | COMPUGEN LTDord | $5,547,000 | -27.6% | 1,289,990 | +0.5% | 0.13% | -20.5% |
| GMDA | Buy | GAMIDA CELL LTD | $5,472,000 | -35.0% | 2,154,300 | +0.3% | 0.13% | -28.8% |
| PRLD | Buy | PRELUDE THERAPEUTICS INC | $4,594,000 | -59.4% | 368,959 | +1.8% | 0.11% | -55.5% |
| EDAP | EDAP TMS S Asponsored adr | $4,558,000 | -6.1% | 760,900 | 0.0% | 0.10% | +2.9% | |
| TPST | Buy | TEMPEST THERAPEUTICS INC | $4,349,000 | -3.1% | 823,654 | +165.6% | 0.10% | +6.4% |
| FUSN | FUSION PHARMACEUTICALS INC | $3,955,000 | -47.3% | 948,327 | 0.0% | 0.09% | -42.4% | |
| FSTX | Sell | F-STAR THERAPEUTICS INC | $3,774,000 | -51.1% | 751,889 | -28.7% | 0.09% | -46.3% |
| TRAVERE THERAPEUTICS INCnote 2.500% 9/1 | $3,589,000 | +9.6% | 3,250,000 | 0.0% | 0.08% | +20.3% | ||
| ACRX | Buy | ACELRX PHARMACEUTICALS INC | $3,544,000 | -9.0% | 6,325,902 | +65.6% | 0.08% | 0.0% |
| BLSA | BCLS ACQUISITION CORP | $3,028,000 | -1.6% | 309,000 | 0.0% | 0.07% | +7.7% | |
| STTK | SHATTUCK LABS INC | $2,668,000 | -58.2% | 313,499 | 0.0% | 0.06% | -53.7% | |
| JYAC | JIYA ACQUISITION CORP | $2,015,000 | +0.2% | 206,200 | 0.0% | 0.05% | +11.9% | |
| PSTX | POSEIDA THERAPEUTICS INC | $1,973,000 | -6.6% | 289,754 | 0.0% | 0.05% | +4.5% | |
| IMRA | Buy | IMARA INC | $1,895,000 | -44.0% | 842,302 | +1.6% | 0.04% | -38.0% |
| THERAVANCE BIOPHARMA INCnote 3.250%11/0 | $1,456,000 | +4.7% | 1,500,000 | 0.0% | 0.03% | +17.2% | ||
| RADIUS HEALTH INCnote 3.000% 9/0 | $1,459,000 | +6.5% | 1,500,000 | 0.0% | 0.03% | +17.2% | ||
| BCEL | Buy | ATRECA INC | $1,401,000 | -51.1% | 462,530 | +0.6% | 0.03% | -46.7% |
| NEUROCRINE BIOSCIENCES INCnote 2.250% 5/1 | $1,257,000 | -5.9% | 1,000,000 | 0.0% | 0.03% | +3.6% | ||
| PACIRA BIOSCIENCES INCnote 2.375% 4/0 | $1,029,000 | -0.9% | 1,000,000 | 0.0% | 0.02% | +9.1% | ||
| NEVRO CORPnote 2.750% 4/0 | $556,000 | -17.6% | 500,000 | 0.0% | 0.01% | -7.1% | ||
| NUVBWS | NUVATION BIO INC*w exp 07/07/202 | $253,000 | -26.2% | 134,028 | 0.0% | 0.01% | -14.3% | |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -26,458 | -100.0% | -0.02% | – |
| HLXA | Exit | HELIX ACQUISITION CORP | $0 | – | -154,500 | -100.0% | -0.03% | – |
| PHICU | Exit | POPULATION HEALTH INVS CO INunit 99/99/9999 | $0 | – | -201,044 | -100.0% | -0.04% | – |
| TMPMU | Exit | TURMERIC ACQUISITION CORPunit 10/08/2025 | $0 | – | -206,000 | -100.0% | -0.04% | – |
| EUCRU | Exit | EUCRATES BIOMEDICAL ACQU CORunit 10/23/2027 | $0 | – | -206,000 | -100.0% | -0.04% | – |
| FSII | Exit | FS DEVELOPMENT CORP II | $0 | – | -209,332 | -100.0% | -0.04% | – |
| NUVB | Exit | NUVATION BIO INC | $0 | – | -236,609 | -100.0% | -0.05% | – |
| INNV | Exit | INNOVAGE HLDG CORP | $0 | – | -525,000 | -100.0% | -0.07% | – |
| GRTX | Exit | GALERA THERAPEUTICS INC | $0 | – | -568,252 | -100.0% | -0.10% | – |
| ATAI | Exit | ATAI LIFE SCIENCES NV | $0 | – | -317,628 | -100.0% | -0.10% | – |
| TBPH | Exit | THERAVANCE BIOPHARMA INC | $0 | – | -687,500 | -100.0% | -0.11% | – |
| EAR | Exit | EARGO INC | $0 | – | -975,000 | -100.0% | -0.14% | – |
| Exit | TRILLIUM THERAPEUTICS INC | $0 | – | -628,500 | -100.0% | -0.23% | – | |
| RCKT | Exit | ROCKET PHARMACEUTICALS INC | $0 | – | -403,270 | -100.0% | -0.25% | – |
| BHG | Exit | BRIGHT HEALTH GROUP INC | $0 | – | -1,765,000 | -100.0% | -0.30% | – |
| KURA | Exit | KURA ONCOLOGY INC | $0 | – | -822,500 | -100.0% | -0.32% | – |
| OSH | Exit | OAK STR HEALTH INC | $0 | – | -441,000 | -100.0% | -0.39% | – |
| BOLT | Exit | BOLT BIOTHERAPEUTICS INC | $0 | – | -1,649,248 | -100.0% | -0.44% | – |
| AVIR | Exit | ATEA PHARMACEUTICALS INC | $0 | – | -750,307 | -100.0% | -0.55% | – |
| ALLK | Exit | ALLAKOS INC | $0 | – | -305,706 | -100.0% | -0.68% | – |
| TFX | Exit | TELEFLEX INCORPORATED | $0 | – | -130,000 | -100.0% | -1.03% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INTUITIVE SURGICAL INC | 40 | Q3 2023 | 3.4% |
| NEUROCRINE BIOSCIENCES INC | 39 | Q3 2023 | 4.8% |
| PACIRA PHARMACEUTICALS INC | 39 | Q3 2023 | 2.6% |
| ULTRAGENYX PHARMACEUTICAL IN | 39 | Q3 2023 | 1.9% |
| ACADIA HEALTHCARE COMPANY IN | 38 | Q3 2023 | 4.4% |
| ASCENDIS PHARMA A/S | 35 | Q3 2023 | 1.3% |
| INVITAE CORP | 35 | Q3 2023 | 1.8% |
| BIOMARIN PHARMACEUTICAL INC | 35 | Q3 2023 | 1.3% |
| MACROGENICS INC | 35 | Q3 2023 | 0.5% |
| COLLEGIUM PHARMACEUTICAL INC | 34 | Q3 2023 | 2.1% |
View Rock Springs Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | February 14, 2023 | 3,413,906 | 5.6% |
| Compass Therapeutics, Inc. | February 14, 2023 | 5,333,188 | 4.2% |
| Mirum Pharmaceuticals, Inc. | February 14, 2023 | 1,795,733 | 4.9% |
| PhaseBio Pharmaceuticals IncSold out | February 14, 2023 | 0 | 0.0% |
| Sierra Oncology, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ARDELYX, INC.Sold out | February 15, 2022 | 0 | 0.0% |
| CHIASMA, INCSold out | February 15, 2022 | 0 | 0.0% |
| FIVE PRIME THERAPEUTICS, INC.Sold out | February 15, 2022 | 0 | 0.0% |
| F-star Therapeutics, Inc. | February 15, 2022 | 751,889 | 3.6% |
| Protara Therapeutics, Inc.Sold out | February 15, 2022 | 0 | 0.0% |
View Rock Springs Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-04-05 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Rock Springs Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.